Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 131.0%

Oxford Biomedica plc (OTCMKTS:OXBDFGet Free Report) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 78,300 shares, an increase of 131.0% from the February 13th total of 33,900 shares. Based on an average trading volume of 4,600 shares, the short-interest ratio is currently 17.0 days. Approximately 0.1% of the company’s stock are sold short.

Oxford Biomedica Price Performance

Oxford Biomedica stock opened at $3.53 on Friday. The company’s fifty day simple moving average is $4.79 and its 200-day simple moving average is $4.97. The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. Oxford Biomedica has a 12 month low of $2.40 and a 12 month high of $5.68.

Oxford Biomedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Stories

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.